Cabozantinib CAS No.:849217-68-1

News 2025-04-09

Cabozantinib (CAS No.: 849217-68-1) 

1. Basic Information

  • Chemical Name: N-(4-(6,7-Dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
  • Molecular Formula: C₂₈H₂₄FN₃O₅
  • Molecular Weight: 501.51 g/mol
  • Appearance: White to off-white crystalline powder
  • Solubility: Slightly soluble in water, soluble in organic solvents (e.g., DMSO, ethanol)

2. Mechanism of Action

Cabozantinib is a multi-targeted tyrosine kinase inhibitor (TKI) that primarily inhibits:

  • MET
  • VEGFR2 (Vascular Endothelial Growth Factor Receptor 2)
  • RET
  • AXL
  • ROS1

By blocking these signaling pathways, cabozantinib suppresses tumor cell proliferation, angiogenesis, and metastasis.

3. Indications

  • Medullary Thyroid Cancer (FDA-approved, 2012)
  • Advanced Renal Cell Carcinoma (RCC) (FDA-approved, 2016)
  • Hepatocellular Carcinoma (HCC) (FDA-approved, 2019)
  • Other Solid Tumors (e.g., prostate cancer, bone metastases; investigational uses in clinical trials)

4. Dosage Forms & Strengths

  • Tablets: 20 mg, 40 mg, 60 mg (Brand names: Cometriq®Cabometyx®)
  • Recommended Dosage: Typically 60 mg once daily (taken on an empty stomach).

5. Adverse Effects

Common side effects include:

  • Diarrhea, decreased appetite
  • Palmar-plantar erythrodysesthesia (hand-foot syndrome)
  • Hypertension, fatigue
  • Elevated liver enzymes

6. Precautions & Warnings

  • Monitoring Required: Blood pressure, liver function, and thyroid function tests.
  • Drug Interactions: Strong CYP3A4 inhibitors or inducers may alter plasma concentrations.
  • Contraindications: Pregnancy (embryotoxic potential).

7. Research & Market Status

  • Originator: Exelixis (USA)
  • Patent Status: Some patents have expired, leading to generic versions in certain markets.

8. Storage Conditions

  • Store in a tightly sealed container, protected from light, at ≤25°C。

 

Property Details
Chemical Name N-(4-(6,7-Dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Molecular Formula C28H24FN3O5
Molecular Weight 501.506 g/mol
Density 1.4 ± 0.1 g/cm³
Boiling Point 758.1 ± 60.0 °C at 760 mmHg
Solubility Practically insoluble in water; soluble in DMSO
Storage Conditions Sealed in dry, room temperature

Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.